On Tuesday, Organogenesis Holdings Inc (NASDAQ: ORGO) was 2.85% up from the session before settling in for the closing price of $4.21. A 52-week range for ORGO has been $2.16 – $6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 14.32% over the past five years. When this article was written, the company’s average yearly earnings per share was at 625.00%. With a float of $64.38 million, this company’s outstanding shares have now reached $125.73 million.
Let’s look at the performance matrix of the company that is accounted for 869 employees. In terms of profitability, gross margin is 74.32%, operating margin of -0.27%, and the pretax margin is -0.58%.
Organogenesis Holdings Inc (ORGO) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Organogenesis Holdings Inc stocks. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 47.79%. The most recent insider transaction that took place on Mar 04 ’25, was worth 127,000. Before that another transaction happened on Mar 04 ’25, when Company’s Director sold 25,000 for $5.10, making the entire transaction worth $127,535. This insider now owns 166,879 shares in total.
Organogenesis Holdings Inc (ORGO) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 625.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
You can see what Organogenesis Holdings Inc (ORGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.14. Likewise, its price to free cash flow for the trailing twelve months is 131.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.19 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 1.45 million, a negative change from its year-to-date volume of 1.75 million. As of the previous 9 days, the stock’s Stochastic %D was 82.81%. Additionally, its Average True Range was 0.35.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 37.94%, which indicates a significant decrease from 87.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.06% in the past 14 days, which was lower than the 135.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.39, while its 200-day Moving Average is $3.45. Nevertheless, the first resistance level for the watch stands at $4.46 in the near term. At $4.58, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.74. If the price goes on to break the first support level at $4.18, it is likely to go to the next support level at $4.02. Assuming the price breaks the second support level, the third support level stands at $3.90.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are 126,828K outstanding shares of the company, which has a market capitalization of 549.17 million. As of now, sales total 482,040 K while income totals 860 K. Its latest quarter income was 126,660 K while its last quarter net income were 7,670 K.
